A new translational strategy for tailored treatment of type 2 diabetes

Project Information

TRANSLATIONAL

Grant agreement ID: 866510

DOI

10.3030/866510

Project closed

EC signature date 17 February 2020

Start date 1 October 2020

End date 30 September 2025

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 1 957 230,00

EU contribution

€ 1 957 230,00

Coordinated by

GOETEBORGS UNIVERSITET
Sweden

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology

Author(s): Chinmay Dwibedi, Ola Ekström, Jasmine Brandt, Martin Adiels, Stefan Franzén, Birgitta Abrahamsson, Anders H. Rosengren
Published in: Nature Metabolism, Issue 6, 2024, Page(s) 50-60, ISSN 2522-5812
Publisher: Springer Science and Business Media LLC
DOI: 10.1038/s42255-023-00943-3

Effect of broccoli sprout extract and baseline gut microbiota on fasting blood glucose in prediabetes: a randomized, placebo-controlled trial

Author(s): Chinmay Dwibedi, Annika S. Axelsson, Birgitta Abrahamsson, Jed W. Fahey, Olof Asplund, Ola Hansson, Emma Ahlqvist, Valentina Tremaroli, Fredrik Bäckhed, Anders H. Rosengren
Published in: Nature Microbiology, Issue 10, 2025, Page(s) 681-693, ISSN 2058-5276
Publisher: Springer Science and Business Media LLC
DOI: 10.1038/s41564-025-01932-w